The burgeoning UK scene surrounding entheogens is increasingly complex, demanding careful navigation. While therapeutic investigation into compounds like psilocybin and copyright continues to progress, and patient opportunity via private clinics is growing, the legal framework remains unclear. This presents a challenging situation for both seekers